Correlation of glycemic regulation and endotrophin in patients with type 2 Diabetes; pilot study

Table 3 Patient outcomes at baseline and the end of 3 months

	Normal ranges	Baseline n = 42	Third Month n = 42	p value
Endotrophin	–	15.35 ± 9.77	12.20 ± 6.49	0.010
HbA1c (%)	≤ 7	10.90 ± 1.71	6.64 ± 0.36	< 0.001
Fasting glucose (mg/dL)	< 104	258.97 ± 93.55	125.97 ± 14.63	< 0.001
CRP (mg/L)	0–5	6.01 ± 4.24	4.60 ± 3.69	0.050
BMI (kg/m²)	18–25	29.37 ± 4.64	29.29 ± 4.41	0.412
HDL, mg/dL	> 50	43.92 ± 8.96	44.14 ± 8.38	0.865
LDL, mg/dL	< 130	144.14 ± 32.64	136 ± 69 ± 30.82	0.160
TG, mg/dL	< 150	197.97 ± 100.22	180.66 ± 78.71	0.208
UACR, mg/g	0–30	15.35 ± 16.04	10.80 ± 9.75	< 0.001

BMI body mass index, HbA1c hemoglobin A1c, CRP, C-reactive protein, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, TG triglyceride, UACR urinary albumin to creatinine(mg/g) ratio

ISSN: 1758-5996